CGS 27023A

CAS : 161314-82-5

Ref. 3D-LGA31482

Informations sur le produit

• Nom: CGS 27023A
• Synonymes: Butanamide,N-hydroxy-2-[[(4-methoxyphenyl)sulfonyl](3-pyridinylmethyl)amino]-3-methyl-,monohydrochloride, (2R)- (9CI), Cgs 27023, Cgs 27023A, Cona 60, Mmi 270, Mmi270B

Description

CGS 27023A is a monoclonal antibody that binds to the hydrophobic pocket of metalloproteases, leading to inhibition of their activity. This drug has been shown to have anti-inflammatory and matrix metalloproteinase inhibiting effects, which may be useful for the treatment of inflammatory diseases such as arthritis. CGS 27023A also inhibits angiogenesis and endothelial cell proliferation in vitro, which may be useful for the treatment of cancer. CGS 27023A has been shown to inhibit collagen-induced arthritis in mice.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 429.9 g/mol
• Formule: C₁₈H₂₄ClN₃O₅S
• Degré de pureté: Min. 95%